Christopher W. Farnsworth, PhD

Education

• PhD: Pathology, University of Rochester, Rochester, NY (2017)
• Fellowship, Clinical Chemistry: Washington University School of Medicine, St. Louis, MO (2019)

Awards

• Paul E. Strandjord Young Investigator Award. Academy of Clinical Laboratory Physicians and Scientists annual meeting. Salt Lake City, UT (2019)
• Runner Up, Best-oral presentation. American Association for Clinical Chemistry annual meeting. Anaheim, CA (2019)
• Outstanding Achievements in Leadership and Professionalism Award, Washington University Department of Pathology & Immunology (2020)
• Special Recognition Award, nominated for development of SARS-CoV-2 testing. Washington University Department of Pathology & Immunology (2020)
• Distinguished Abstract Award, 2021 AACC Annual Meeting (2021)
• George Grannis Award for Excellence in Research and Scientific Publication. AACC Academy (2021)
• BJC Team Award for Quality Improvement (TAQI): Reducing Quantity Not Sufficient Specimens (2021)
• Outstanding Scientific Achievements by a Young Investigator, AACC (2022)
• Outstanding Clinical Paper of the Year, Washington University Department of Pathology & Immunology (2022)

Research Interests

My research aims to improve patient care by refining, discovering, and implementing biomarkers for the detection and prediction of disease, particularly in acute and critical care settings. My specific interests include the use of biomarkers to aid in the diagnosis and prognostication of infectious disease including sepsis and viral infections. I am also interested in the use of cardiac biomarkers as a measure of cardiotoxicity in both the acute and chronic care settings. Finally, I am interested in the preanalytical phase of testing and identifying variables that impact laboratory results.

Lab Webpage

Pathology Research Collaborative

---

Assistant
Julie Shafferkoetter
314-362-3186
shafferkoetterj@wustl.edu
BJCIH Room 4410